LAVAL, QC, Aug. 12 /CNW/ - BioSyntech, Inc. (TSX: BSY), a biotechnology
company developing biotherapeutic thermogels for regenerative medicine, today
announced its financial and operational results for first quarter of its
fiscal year 2009, ended June 30, 2008.
